Clinical Programs

FAQs

Below are some of the most frequently asked questions about our company.  If you don't find what you're looking for here, please contact us directly.

1. What exchange does Therapix trade on and what is the company’s ticker symbol?

Therapix trades on NASDAQ under the ticker TRPX.

2. Can I buy stock directly from Therapix?

Only when the company raises funds and is subject to issuance by the company.

3. How can I buy stock in Therapix?

Through a licensed stock broker or by using an online trading account.

4. When did Therapix become a publicly traded company?

March 2017 on NASDAQ

5. When does Therapix Fiscal Year End?

By December 31st

6. Does Therapix pay dividends?

Therapix does not currently have a dividend plan.

7. How do I contact Investor Relations?

To reach out to Investor Relations, please contact us at
IR@therapixbio.com or info@therapixbio.com

8. How do I get more information about Therapix?

Please explore our website, our Press Releases or contact Info@therapixbio.com

9. How do I change the address on my shareholder account, or replace a lost stock certificate?

Through your licensed stock broker

10. Who is Therapix transfer agent?

The Bank of New York Mellon

11. Who is Therapix Auditor?

Kost Forer Gabbay & Kasierer a member of Ernst & Young Global

12. When is your next earnings release scheduled? How can I receive email updates for this information?

We announce our earnings release every quarter. To receive email updates, please sign up for alerts here.

13. What is a 505(b)(2) Regulatory Pathway?

The 505(b)(2) is an FDA regulatory pathway with abbreviated development costs and potentially expedited time to market.

14. Which indications are Therapix treating and in which clinical trial phase are they at?

Therapix is engaged in drug development for THX-110 for the treatment of Tourette syndrome (Phase IIb), Obstructive Sleep Apnea (Phase IIa) and chronic pain (Phase IIa), THX-130 for the treatment of Traumatic Brain Injury and Mild Cognitive Impairment (pre-clinical), THX-150 for the treatment of infectious disease (pre-clinical) and THX-160 for chronic pain (pre-clinical). Please see our clinical pipeline here.

15. Where can I access Therapix latest presentations and fact sheet?

Therapix most recent Investor materials can be found here.

16. Where is Therapix located?

Therapix Biosciences
4 Ariel Sharon St.
HaShahar Tower, 16th floor
Givatayim, IL 5320047

17. When will Therapix delist from TASE?

Therapix officially delisted from the Tel Aviv Stock Exchange (TASE) on August 9th, 2018.

18. How do I get news updates from Therapix?

For news updates, please sign up for alerts here.

19. How do I obtain SEC regulatory filings for Therapix?

To obtain SEC regulatory filings, please visit EDGAR. You can also view them on the SEC Filings page of our website.

20. When is Therapix Annual Meeting of Stockholders?

The date and location of the Therapix Annual Meeting of Stockholders for 2018 has not yet been announced.